LIMLEAD project selected by the Canceropole CLARA for its Proof of Concept 2013 Grant.
LIMLEAD is an applied research collaboration project between Institut Albert Bonniot, Grenoble and CELLIPSE.
The aim is to validate a first-in-class LIM kinase inhibitor drug candidate in various models in-vivo and ex-vivo as well as to stratify patients populations according to various « omics » signatures e.g. genomics, proteomics, transcriptomics.
LIMLEAD was one of the three projects selected by the CLARA among over twenty projects submitted.